Cancer drug vidaza tested as heart treatment – but only one patient joined
NCT ID NCT03298321
First seen Apr 25, 2026 · Last updated May 12, 2026 · Updated 1 time
Summary
This study looked at whether Vidaza, a drug used for acute leukemia, could also help treat atrial fibrillation (an irregular heartbeat). The idea was that Vidaza might reverse certain DNA changes that lower the activity of a gene important for heart function. Only one person took part, and researchers tracked heart rhythm and heart structure changes over 6 to 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Léon Berard
Lyon, 69008, France
-
Hopital Lyon Sud
Pierre-Bénite, 69310, France
-
Service de rythmologie - GH Est-Hôpital Louis Pradel - CHU de Lyon HCL
Bron, 69229, France
Conditions
Explore the condition pages connected to this study.